| P2093 | author name string | Wen Xiao | |
| | Lei Liu | |
| | Xiaoping Zhang | |
| | Ke Chen | |
| | Di Liu | |
| | Hongmei Yang | |
| | Zhiyong Xiong | |
| | Yan Qu | |
| | Wencheng Li | |
| | Lin Bao | |
| | Xiong Yang | |
| | Junwei Tong | |
| | Changfei Yuan | |
| | Haibing Xiao | |
| P2860 | cites work | A role for NBR1 in autophagosomal degradation of ubiquitinated substrates | Q24316135 |
| | Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling | Q24324825 |
| | Cell signaling by receptor tyrosine kinases | Q24598357 |
| | Modes of resistance to anti-angiogenic therapy | Q24608005 |
| | HIF2a inhibitors for the treatment of VHL disease | Q26795629 |
| | HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression | Q27025886 |
| | Solution Structure of the Ubiquitin-associated (UBA) Domain of Human Autophagy Receptor NBR1 and Its Interaction with Ubiquitin and Polyubiquitin | Q27682743 |
| | NBR1 interacts with fasciculation and elongation protein zeta-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tube | Q28202584 |
| | A perspective on cancer cell metastasis | Q28307891 |
| | Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity | Q28510813 |
| | Mammalian sprouty-1 and -2 are membrane-anchored phosphoprotein inhibitors of growth factor signaling in endothelial cells | Q28609619 |
| | Renal cell carcinoma | Q30235364 |
| | Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features | Q34866372 |
| | Feasibility analysis of p62 (SQSTM1)-encoding DNA vaccine as a novel cancer immunotherapy. | Q35626579 |
| | Optimization of dosing for EGFR-mutant non-small cell lung cancer with evolutionary cancer modeling | Q36406541 |
| | Deconvoluting the context-dependent role for autophagy in cancer | Q36876716 |
| | Fast clearance of lipid droplets through MAP1S-activated autophagy suppresses clear cell renal cell carcinomas and promotes patient survival | Q36905895 |
| | Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors | Q37069569 |
| | External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology | Q37343211 |
| | Targeting renal cell carcinoma with a HIF-2 antagonist. | Q37684974 |
| | p62: a versatile multitasker takes on cancer | Q37994350 |
| | Cancer diagnostics: The journey from histomorphology to molecular profiling. | Q38559476 |
| | The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours | Q38758269 |
| | HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. | Q38892263 |
| | Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy | Q38975732 |
| | Autophagy mediates HIF2α degradation and suppresses renal tumorigenesis. | Q38977659 |
| | Cancer Statistics, 2017. | Q39038674 |
| | Nbr1 is a novel inhibitor of ligand-mediated receptor tyrosine kinase degradation | Q39645635 |
| | Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma | Q39747597 |
| | Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors | Q41593373 |
| | Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients | Q42700879 |
| | An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score | Q44231764 |
| | Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohort | Q44263400 |
| | NBR1 cooperates with p62 in selective autophagy of ubiquitinated targets. | Q47929108 |
| | Renal cell carcinoma: An update for the practicing urologist | Q53649433 |
| | Metastasis in renal cell carcinoma: Biology and implications for therapy. | Q54936635 |
| | Renal cell carcinoma | Q56019530 |
| | Expression of BRCA1, NBR1 and NBR2 genes in human breast cancer cells | Q74385979 |
| | Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score | Q83198625 |
| P433 | issue | 55 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 94819-94833 | |
| P577 | publication date | 2017-10-23 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Low neighbor of Brca1 gene expression predicts poor clinical outcome and resistance of sunitinib in clear cell renal cell carcinoma | |
| P478 | volume | 8 | |